Premier Partners — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Qurientqurient.comDec 2023

Korean biotech founded in 2008 that develops oncology and anti-infective drug candidates via a 'Network R&D' virtual model.

Co-investorsAtinum Investment Co. Ltd.LB Investment

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.